Global Therapeutic Drug Monitoring (TDM) Technologies, Markets & Companies Report 2020: Description of 35 Companies Involved with Their Collaborations in this Area

Dublin, Nov. 03, 2020 (GLOBE NEWSWIRE) -- The "Therapeutic Drug Monitoring - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to's offering.

This report deals with therapeutic drug monitoring, a multi-disciplinary clinical specialty, aimed at improving patient care by monitoring drug levels in the blood to individually adjust the dose of drugs for improving outcome.

TDM is viewed as a component of personalized medicine that interacts with several other disciplines including pharmacokinetics and pharmacogenetics. One chapter is devoted to the monitoring of drugs of abuse (DoA). Various technologies used for well-known DoA are described. A section on drug abuse describes methods of detection of performance-enhancing drugs.

The TDM market is analyzed from 2019 to 2029 according to technologies as well as geographical distribution. The global market for DoA testing was also analyzed from 2018 to 2028 and divided according to the area of application.

Unmet needs and strategies for the development of markets for TDM are discussed. The report contains profiles of 35 companies involved in developing tests and equipment for drug monitoring along with their collaborations. The text is supplemented with 21 tables, 9 figures, and 210 selected references from literature.

Benefits of this report

  • Up-to-date one-stop information on therapeutic drug monitoring
  • Description of 35 companies involved with their collaborations in this area
  • Market analysis 2019-2029
  • Market values in major regions
  • Strategies for developing markets for therapeutic drug monitoring
  • A selected bibliography of 210 publications
  • Text is supplemented by 21 tables and 9 figures

Who should read this report?

  • Biotechnology companies developing assays and equipment for drug monitoring
  • Reference laboratories providing drug monitoring services
  • Pharmaceutical companies interested in companion tests for monitoring their drugs
  • Clinical pharmacologists interested in integrating therapeutic drug monitoring with pharmacogenetics for development of personalized medicine

Key Topics Covered:

Executive Summary

1. Introduction

2. Technologies for TDM

3. Drug Monitoring Instruments

4. Applications of TDM

5. Drugs Requiring Monitoring

6. Monitoring of Biological Therapies

7. Monitoring of Drug Abuse

8. Markets for TDM

9. Companies

10. References

For more information about this report visit

Source: Jain PharmaBiotech

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.


Contact Data